Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.47 -0.03 (-6.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Non-Current Debt (2020)

Updated

Reviva Pharmaceuticals Holdings' Non-Current Debt was $1.98 million in Q3 2020, up 38.6% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Non-Current Debt (2020) Analysis & Trends

At the end of FY2019, Non-Current Debt at Reviva Pharmaceuticals Holdings came in at $750,000.

  • Per Business Quant data, RVPH's Non-Current Debt in the three quarters before Q3 2020 was $1.43 million (Q2 2020), $1.13 million (Q1 2020) and $750,000 (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 37.34 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 62.48 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -108.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 23.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Reviva Pharmaceuticals Holdings 6.16 Mn 6.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2020 1.98 Mn
Aug 31, 2020 1.43 Mn
May 31, 2020 1.13 Mn
Feb 29, 2020 750,000.00
API Access

Reviva Pharmaceuticals Holdings Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RVPH&period=max&api_key=YOUR_API_KEY